
### [Orphanet:156146](http://www.orpha.net/ORDO/Orphanet_156146)
**Label:** Predominantly small-vessel vasculitis

**Subclasses:** [Orphanet:375](http://www.orpha.net/ORDO/Orphanet_375) (Anti-glomerular basement membrane disease), [Orphanet:425120](http://www.orpha.net/ORDO/Orphanet_425120) (STING-associated vasculopathy with onset in infancy), 

**Corr. equiv. classes:** [Orphanet:375](http://www.orpha.net/ORDO/Orphanet_375), [OMIM:615934](http://purl.obolibrary.org/obo/OMIM_615934), [Orphanet:425120](http://www.orpha.net/ORDO/Orphanet_425120), [OMIM:233450](http://purl.obolibrary.org/obo/OMIM_233450), 

**Class expressions from DL-Learner:**

- [HP:0025300](http://purl.obolibrary.org/obo/HP_0025300) (Malar rash) and [HP:0200039](http://purl.obolibrary.org/obo/HP_0200039) (Pustule) 62.50%
- [HP:0025300](http://purl.obolibrary.org/obo/HP_0025300) (Malar rash) and [HP:0100614](http://purl.obolibrary.org/obo/HP_0100614) (Myositis) 62.50%
- [HP:0025300](http://purl.obolibrary.org/obo/HP_0025300) (Malar rash) and [HP:0030880](http://purl.obolibrary.org/obo/HP_0030880) (Raynaud phenomenon) 62.50%
- [HP:0025300](http://purl.obolibrary.org/obo/HP_0025300) (Malar rash) and [HP:0030163](http://purl.obolibrary.org/obo/HP_0030163) (Abnormal vascular physiology) 62.50%
- [HP:0025300](http://purl.obolibrary.org/obo/HP_0025300) (Malar rash) and [HP:0025323](http://purl.obolibrary.org/obo/HP_0025323) (Abnormal arterial physiology) 62.50%
- [HP:0025142](http://purl.obolibrary.org/obo/HP_0025142) (Constitutional symptom) and [HP:0025300](http://purl.obolibrary.org/obo/HP_0025300) (Malar rash) 62.50%
- [HP:0025021](http://purl.obolibrary.org/obo/HP_0025021) (Abnormal erythrocyte sedimentation rate) and [HP:0025300](http://purl.obolibrary.org/obo/HP_0025300) (Malar rash) 62.50%
- [HP:0012531](http://purl.obolibrary.org/obo/HP_0012531) (Pain) and [HP:0025300](http://purl.obolibrary.org/obo/HP_0025300) (Malar rash) 62.50%
- [HP:0012252](http://purl.obolibrary.org/obo/HP_0012252) (Abnormal respiratory system morphology) and [HP:0025300](http://purl.obolibrary.org/obo/HP_0025300) (Malar rash) 62.50%
- [HP:0011947](http://purl.obolibrary.org/obo/HP_0011947) (Respiratory tract infection) and [HP:0025300](http://purl.obolibrary.org/obo/HP_0025300) (Malar rash) 62.50%
- [HP:0011842](http://purl.obolibrary.org/obo/HP_0011842) (Abnormality of skeletal morphology) and [HP:0025300](http://purl.obolibrary.org/obo/HP_0025300) (Malar rash) 62.50%
- [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) and [HP:0025300](http://purl.obolibrary.org/obo/HP_0025300) (Malar rash) 62.50%
- [HP:0011729](http://purl.obolibrary.org/obo/HP_0011729) (Abnormality of joint mobility) and [HP:0025300](http://purl.obolibrary.org/obo/HP_0025300) (Malar rash) 62.50%
- [HP:0011138](http://purl.obolibrary.org/obo/HP_0011138) (Abnormality of skin adnexa morphology) and [HP:0025300](http://purl.obolibrary.org/obo/HP_0025300) (Malar rash) 62.50%
- [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) and [HP:0025300](http://purl.obolibrary.org/obo/HP_0025300) (Malar rash) 62.50%


